Lipase inhibitor

A - Human Necessities – 61 – K

Patent

Rate now

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Details

A61K 31/23 (2006.01) A23L 1/30 (2006.01) A61K 31/231 (2006.01) A61P 3/04 (2006.01) A61P 3/06 (2006.01) A61P 43/00 (2006.01) C12N 9/99 (2006.01)

Patent

CA 2551119

It is intended to provide a fat-soluble lipase inhibitor which can contribute to the prevention or treatment of obesity or diseases caused by obesity due to excessive fat intake and mildly inhibit hydrolysis by lipase when added to fats and oils of any types. Namely, a lipase inhibitor containing, as the active ingredient, at least one substance which is a fat-soluble substance selected from among SLS type triacylglycerols (i.e., symmetric triacylglycerols composed of S which represents a short-chain fatty acid having from 2 to 6 carbon atoms and L which represents a long-chain fatty acid having from 16 to 22 carbon atoms), LUU type and UUL type triacylglycerols (i.e., asymmetric triacylglycerols composed of L which represents a long-chain fatty acid having from 16 to 22 carbon atoms and U which represents an unsaturated fatty acid having from 16 to 22 carbon atoms) and glyceryl ether lipids wherein a long-chain alkyl chain or an alkenyl chain is attached to the 1- or 3-position of glycerol via an ether bond.

L'invention concerne un inhibiteur de la lipase liposoluble, qui peut contribuer à la prévention ou au traitement de l'obésité ou de maladies imputables à l'obésité due à une prise de graisse excessive, et inhiber en douceur l'hydrolyse par la lipase lorsqu'il est ajouté à des corps gras de types quelconques. L'invention concerne un inhibiteur de la lipase qui contient, comme ingrédient actif, au moins une substance liposoluble sélectionnée dans le groupe constitué par les triacylglycérols de type SLS (c.-à-d. des triacylglycérols symétriques composés de S qui représente un acide gras à chaîne courte comportant 2 à 6 atomes de carbone, et de L qui représente un acide gras à chaîne longue comportant 16 à 22 atomes de carbone); les triacylglycérols de types LUU et UUL (c.-à-d. des triacylglycérols asymétriques composés de L qui représente un acide gras à chaîne longue comportant 16 à 22 atomes de carbone, et de U qui représente un acide gras insaturé comportant 16 à 22 atomes de carbone); et des lipides d'éther de glycéryle dans lesquels une chaîne alkyle à chaîne longue ou une chaîne alcényle est attachée à la position 1- ou 3- du glycérol par le biais d'une liaison éther.

LandOfFree

Say what you really think

Search LandOfFree.com for Canadian inventors and patents. Rate them and share your experience with other people.

Rating

Lipase inhibitor does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Lipase inhibitor, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Lipase inhibitor will most certainly appreciate the feedback.

Rate now

     

Profile ID: LFCA-PAI-O-1805426

  Search
All data on this website is collected from public sources. Our data reflects the most accurate information available at the time of publication.